Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain

BACKGROUND: Hyperkalaemia (HK) is a common electrolyte disorder in patients with chronic kidney disease (CKD) and/or treated with renin–angiotensin–aldosterone system inhibitors (RAASis). The aim of this study is to determine the severity, current management and cost of chronic HK. METHODS: We perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Olry de Labry Lima, Antonio, Díaz Castro, Óscar, Romero-Requena, Jorge M, García Díaz-Guerra, M de los Reyes, Arroyo Pineda, Virginia, de la Hija Díaz, M Belén, Ascanio, Meritxell, Darbà, Josep, Cruzado, Josep M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573009/
https://www.ncbi.nlm.nih.gov/pubmed/34754435
http://dx.doi.org/10.1093/ckj/sfab076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573009/
https://www.ncbi.nlm.nih.gov/pubmed/34754435
http://dx.doi.org/10.1093/ckj/sfab076

Ejemplares similares